Arrhythmias & electrophysiologySecondary analysis

Early recurrence of atrial tachyarrhythmia after catheter ablation and its associations with clinical outcomes, atrial fibrillation burden, and blanking period duration: a post hoc analysis of the CABANA trial

EuropacePublished

  • Secondary analysis of the CABANA randomised trial
  • post hoc analysis

Authors' conclusion

ERAT was associated with higher risks of cardiovascular hospitalization and late atrial tachyarrhythmia recurrence in a time-dependent manner, supporting a shorter blanking period to better identify patients at risk of adverse rhythm outcomes.

Study context

Population
Patients from the CABANA trial who underwent catheter ablation with trial-specific ECG monitoring data
Participants
811 patients
Comparison
Early recurrence of atrial tachyarrhythmia (ERAT) vs no ERAT after catheter ablation for atrial fibrillation (AF)
  • ERATn = 567
Primary endpoint
Composite of:
  • All-cause mortality
  • Disabling stroke
  • Serious bleeding
  • Cardiac arrest
Follow-up
Median 4 years (IQR 2.5-5.2)

Primary result

As reported in the abstract

Primary composite outcome
  • ERAT: no increased risk of the primary composite outcome

Secondary outcomes

OutcomeaHR (95% CI)
CV hospitalization1.35 (1.07–1.71)
All-cause mortality or CV hospitalization1.33 (1.07–1.66)
Late atrial tachyarrhythmia recurrence1.35 (1.07–1.71)
Late atrial tachyarrhythmia recurrence · ERAT between 60 and 90 days after ablation1.80 (1.16–2.79)
ERAT incidence
69.9% · 567 of 567
Late atrial tachyarrhythmia recurrence — ROC optimal threshold for predicting late recurrence: 58 days
AUC 0.727

Original publication

Early recurrence of atrial tachyarrhythmia after catheter ablation and its associations with clinical outcomes, atrial fibrillation burden, and blanking period duration: a post hoc analysis of the CABANA trial. Europace. Published 7 July 2026. doi:10.1093/europace/euag173

Summarised from the published abstract; every number is checked against it